Search results
Results from the WOW.Com Content Network
The hearings lasted two years, involving many witnesses and thousands of pages of documentation. On September 6, 1988, DEA Chief Administrative Law Judge Francis L. Young ruled that cannabis did not meet the legal criteria of a Schedule I prohibited drug and should be reclassified. He declared that cannabis in its natural form is "one of the ...
The U.S. Drug Enforcement Administration is moving toward reclassifying marijuana as a less dangerous drug. The Justice Department proposal would recognize the medical uses of cannabis, but wouldn ...
The proposed federal change may have little affect in 24 states that already legalized recreational marijuana for adults, or in an additional 14 states that allow medical marijuana.
The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.
The President made descheduling and other cannabis reforms a topic of the 2024 State of the Union Address; [2] it was the first time the word "marijuana" had been used in a State of the Union Address since Ronald Reagan called it a target of the War on Drugs alongside cocaine in 1988. [3]
The use, sale, and possession of cannabis over 0.3% delta-9-THC in the United States, despite state laws, is illegal under federal law.As a Schedule I drug under the federal Controlled Substances Act of 1970, cannabis over 0.3% delta-9-THC (legal term marijuana) is considered to have "no accepted medical use" and have a high potential for abuse and physical or psychological dependence.
The Biden administration plans to reclassify marijuana for the first time since the Controlled Substances Act was enacted more than 50 years ago. DEA to reclassify marijuana, easing restrictions ...
No changes are expected to the medical marijuana programs now licensed in 38 states or the legal recreational cannabis markets in 23 states, but it's unlikely they would meet the federal production, record-keeping, prescribing and other requirements for Schedule III drugs.